Targeting senescent cells in the retina with a BCL-xL inhibitor shows promise as a durable treatment for diabetic macular edema, potentially offering long-term visual function improvements.
Psychedelic Policy Reform & Legal Markets in 2023 – Psychedelic Alpha
The Bay State has been a hotbed of psychedelic policy reform for some time, with at least a half-dozen local jurisdictions in the state having